Diagnostic News and Research

RSS
Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

Adeona reports $979,782 net income for second-quarter 2010 vs. $879,550 net loss for same period in 2009

Adeona reports $979,782 net income for second-quarter 2010 vs. $879,550 net loss for same period in 2009

China Medical Technologies first-quarter fiscal 2010 revenues decrease 10.9% to RMB186.2 million

China Medical Technologies first-quarter fiscal 2010 revenues decrease 10.9% to RMB186.2 million

NewCardio second-quarter net loss decreases to $1.5 million

NewCardio second-quarter net loss decreases to $1.5 million

American CareSource second-quarter revenues decrease to $16.0 million

American CareSource second-quarter revenues decrease to $16.0 million

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

LevPharm to distribute Innovotech's bioFILM PA- test in Israel

LevPharm to distribute Innovotech's bioFILM PA- test in Israel

Problems with analytical study design and data misinterpretation leads to biomarker failure: Report

Problems with analytical study design and data misinterpretation leads to biomarker failure: Report

Alliance HealthCare Services receives Exceeding Patient Expectations Award for 2009

Alliance HealthCare Services receives Exceeding Patient Expectations Award for 2009

Aeterna Zentaris second-quarter revenues decrease to $5.6 million

Aeterna Zentaris second-quarter revenues decrease to $5.6 million

Perrigo fourth-quarter fiscal 2010 net sales up 22%

Perrigo fourth-quarter fiscal 2010 net sales up 22%

Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745

Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745

Komen Advocacy Alliance thanks Congress for 6-month extension of enhanced federal funding for Medicaid

Komen Advocacy Alliance thanks Congress for 6-month extension of enhanced federal funding for Medicaid

AdvanDx announces European launch of CE-IVD marked GNR Traffic Light PNA FISH test

AdvanDx announces European launch of CE-IVD marked GNR Traffic Light PNA FISH test

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

K-State researcher receives grant from NIH to continue cancer research

K-State researcher receives grant from NIH to continue cancer research

Isotechnika second-quarter revenue from continuing operations increases to $1.49 million

Isotechnika second-quarter revenue from continuing operations increases to $1.49 million

Swift Biosciences completes $3 million Series A financing

Swift Biosciences completes $3 million Series A financing

ACR announces revised classification criteria for rheumatoid arthritis

ACR announces revised classification criteria for rheumatoid arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.